UniCredit Shifts Equity Capital Markets Approach, CVC Seeks Partners for Recordati, Seven & i Delays US IPO

UniCredit SpA, an Italian bank, has shifted its approach to equity capital markets (ECM), according to Bloomberg. The bank is now focusing on more selective deal participation amid market conditions. This change aims to align with current economic factors affecting capital raising.

Details of the shift include a reduced emphasis on certain high-volume ECM activities. UniCredit's team is prioritizing deals with stronger fundamentals. The move follows broader trends in European banking where institutions adapt to volatile interest rates and investor sentiment.

Partners is seeking partners for a potential transaction involving Recordati Industria Chimica e Farmaceutica SpA, an Italian pharmaceutical company.

The private equity firm aims to share the investment in acquiring or managing stakes in Recordati. This effort comes as CVC evaluates opportunities in the healthcare sector. Recordati, based in Milan, specializes in treatments for rare diseases and urology.

5 billion euros as of recent reports. Potential partners could include other private equity firms or strategic investors interested in pharmaceuticals.

Postpones US Unit IPO Seven & i Holdings Co Ltd, the Japanese parent of 7-Eleven, has delayed the initial public offering of its US subsidiary, Seven & i Holdings (USA) Inc.

The postponement was announced amid preparations for the listing on the New York Stock Exchange. The delay affects plans to raise capital through the IPO, originally targeted for later this year. The US unit operates over 13,000 convenience stores primarily under the 7-Eleven brand.

Seven & i had aimed to value the unit at up to 40 billion dollars in the offering. The decision follows consultations with underwriters and reflects current market volatility in retail and consumer sectors. These developments occur against a backdrop of global economic uncertainty, including inflation pressures and geopolitical tensions.